<?xml version="1.0" encoding="UTF-8"?>
<?schematron-schema href="../main/schematron/knowledgeartifact.sch"?>
<?schematron-schema href="../main/schematron/documentationtemplates.sch"?>
<knowledgeDocument xmlns="urn:hl7-org:knowledgeartifact:r1" xmlns:vmr="urn:hl7-org:vmr:r2" xmlns:dt="urn:hl7-org:cdsdt:r2"
    xmlns:elm="urn:hl7-org:elm:r1" xmlns:t="urn:hl7-org:elm-types:r1" xmlns:a="urn:hl7-org:cql-annotations:r1" xmlns:p1="http://www.w3.org/1999/xhtml"
    xmlns:xml="http://www.w3.org/XML/1998/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:anf="http://hl7.org/anf"
    xsi:schemaLocation="urn:hl7-org:knowledgeartifact:r1 ../../schema/knowledgeartifact/knowledgedocument.xsd urn:hl7-org:elm:r1 ../../schema/elm/clinicalexpression.xsd urn:hl7-org:elm-types:r1 ../../schema/elm/types.xsd urn:hl7-org:cql-annotations:r1 ../../schema/elm/cqlannotations.xsd">
    <metadata>
        <identifiers>
            <identifier root="urn:va.gov:kbs:knart:artifact:r1" extension="4d362567-c693-5541-a2b0-fb1fa7eb9d1e" identifierName="O15" version="1.0"/>
            <identifier root="urn:va.gov:kbs:contract:VA118-16-D-1008:to:VA-118-16-F-1008-0007" extension="CLIN0008AA"
                identifierName="Contract: VA118-16-D-1008, Task Order (TO): VA-118-16-F-1008-0007, CLIN0008AA"/>
            <identifier root="urn:cognitivemedicine.com:lab:jira" extension="KP-888" identifierName="Jira KP-888"/>
        </identifiers>
        <artifactType value="Order Set"/>
        <schemaIdentifier root="urn:hl7-org:knowledgeartifact:r1" version="1"/>
        <dataModels>
            <modelReference>
                <description value="VA Analysis Normal Form Model"/>
                <referencedModel value="urn:solor.io:anf-model:1.0"/>
            </modelReference>
        </dataModels>
        <title value="Recommended Immunizations Order Set"/>
        <relatedResources>
            <relatedResource>
                <relationship value="DerivedFrom"/>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier root="urn:va.gov:kbs:knart:ccwp:r1" extension="O15" version="01"
                                identifierName="Primary Care: Recommended Immunizations"/>
                            <identifier root="LocalDocBook" extension="sr1" identifierName="CCWP"/>
                        </identifiers>
                        <title value="Recommended Immunizations Clinical Content White Paper"/>
                        <description value="Clinical Content White Paper"/>
                    </resource>
                </resources>
            </relatedResource>
            <relatedResource>
                <relationship value="AssociatedResource"/>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier root="LocalDocBook" identifierName="CSD" extension="sr2"/>
                            <identifier root="urn:va.gov:kbs:contract:VA118-16-D-1008:to:VA-118-16-F-1008-0007" extension="CLIN0008AA"
                                identifierName="Contract: VA118-16-D-1008, Task Order (TO): VA-118-16-F-1008-0007, CLIN0008AA"/>
                        </identifiers>
                        <title value="Recommended Immunizations Order Set Conceptual Structure Document"/>
                    </resource>
                </resources>
            </relatedResource>
            <relatedResource>
                <relationship value="AssociatedResource"/>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier root="LocalDocBook" identifierName="KVRpt" extension="sr3"/>
                            <identifier root="urn:va.gov:kbs:contract:VA118-16-D-1008:to:VA-118-16-F-1008-0007" extension="CLIN0008AA"
                                identifierName="Contract: VA118-16-D-1008, Task Order (TO): VA-118-16-F-1008-0007, CLIN0008AA"/>
                        </identifiers>
                        <title value="Recommended Immunizations Order Set KNART Validation Report"/>
                    </resource>
                </resources>
            </relatedResource>
        </relatedResources>
        <supportingEvidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e1" identifierName="ACIP 2017a" root="LocalDocBook"/>
                        </identifiers>
                        <title value="Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger, UNITED STATES, 2017"/>
                        <location value="https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf"/>
                        <citation
                            value="Advisory Committee on Immunization Practices. Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger, UNITED STATES, 2017. https://www.cdc.gov/vaccines/schedules/downloads/child/0-18yrs-child-combined-schedule.pdf. Published February 6, 2017"
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e2" identifierName="ACIP 2017b" root="LocalDocBook"/>
                        </identifiers>
                        <title value="Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017"/>
                        <location value="https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf"/>
                        <citation
                            value="Advisory Committee on Immunization Practices. Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017. https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf. Published February 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e3" identifierName="CDC 2012a" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012"/>
                        <location value="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6125a4.htm"/>
                        <citation
                            value="Centers for Disease Control and Prevention (CDC). “Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012”. MMWR Morb Mortal Wkly Rep. 2012 Jun 29. 61. 25. 468-70"
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e4" identifierName="CDC 2010a" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010"/>
                        <location value="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6001a4.htm"/>
                        <citation
                            value="Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR Morb Mortal Wkly Rep. 2011 Jan 14;60(1):13-5"
                        />
                    </resource>
                </resources>
            </evidence>

            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e5" identifierName="CDC 2013" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)"/>
                        <location value="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6225a3.htm"/>
                        <citation
                            value="Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013 Jun 28;62(25):521-4"
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e6" identifierName="CDC 2012b" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP)"/>
                        <location value="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6140a4.htm"/>
                        <citation
                            value="Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012 Oct 12;61(40):816-9."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e7" identifierName="CDC 2011" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP)"/>
                        <location value="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6050a4.htm"/>
                        <citation
                            value="Centers for Disease Control and Prevention (CDC). Use of hepatitis B vaccination for adults with diabetes mellitus: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2011 Dec 23;60(50):1709-11"
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e8" identifierName="CDC 2010b" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23)"/>
                        <location value="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5934a3.htm"/>
                        <citation
                            value="Centers for Disease Control and Prevention (CDC); Advisory Committee on Immunization Practices. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010 Sep 3;59(34):1102-6."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="10.1098/rstb.2013.0433" identifierName="DOI" root="https://doi.org"/>
                            <identifier extension="e9" identifierName="Greenwood 2014" root="LocalDocBook"/>
                        </identifiers>
                        <title value="The contribution of vaccination to global health: past, present and future"/>
                        <location value="https://doi.org/10.1098/rstb.2013.0433"/>
                        <citation
                            value="Greenwood B. The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130433"
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="10.15585/mmwr.mm6434a4" identifierName="DOI" root="https://doi.org"/>
                            <identifier extension="e10" identifierName="Kobayashi 2015" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)"/>
                        <location value="https://doi.org/10.15585/mmwr.mm6434a4"/>
                        <citation
                            value="Kobayashi M, Bennett NM, Gierke R, et al. Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2015 Sep 4;64(34):944-7."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="10.1111/ajt.14426" identifierName="DOI" root="https://doi.org"/>
                            <identifier extension="e11" identifierName="McNamara 2017" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine."/>
                        <location value="https://doi.org/10.1111/ajt.14426"/>
                        <citation
                            value="McNamara LA, Topaz N, Wang X, Hariri S, Fox L, and MacNeil JR. High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine. MMWR Morb Mortal Wkly Rep. 2017 Jul 14;66(27):734-737"
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="10.1111/ajt.14206" identifierName="DOI" root="https://doi.org"/>
                            <identifier extension="e12" identifierName="Meites 2016" root="LocalDocBook"/>
                        </identifiers>
                        <title value="Use of a 2-Dose Schedule for Human Papillomavirus Vaccination"/>
                        <location value="https://doi.org/10.1111/ajt.14206"/>
                        <citation
                            value="Meites E, Kempe A, and Markowitz LE. Use of a 2-Dose Schedule for Human Papillomavirus Vaccination - Updated Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2016 Dec 16;65(49):1405-1408"
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e13" identifierName="NCHPDP 2017a" root="LocalDocBook"/>
                        </identifiers>
                        <title value="Get Recommended Screening Tests and Immunizations for Men"/>
                        <location value="https://www.prevention.va.gov/Healthy_Living/Get_Recommended_Screening_Tests_and_Immunizations_for_Men.asp"/>
                        <citation
                            value="National Center for Health Promotion and Disease Prevention. Get Recommended Screening Tests and Immunizations for Men. National Center for Health Promotion and Disease Prevention website. https://www.prevention.va.gov/Healthy_Living/Get_Recommended_Screening_Tests_and_Immunizations_for_Men.asp. Accessed August 23, 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e14" identifierName="NCHPDP 2017b" root="LocalDocBook"/>
                        </identifiers>
                        <title value="Get Recommended Screening Tests and Immunizations for Women."/>
                        <location value="https://www.prevention.va.gov/Healthy_Living/Get_Recommended_Screening_Tests_and_Immunizations_for_Women.asp"/>
                        <citation
                            value="National Center for Health Promotion and Disease Prevention. Get Recommended Screening Tests and Immunizations for Women. National Center for Health Promotion and Disease Prevention website. https://www.prevention.va.gov/Healthy_Living/Get_Recommended_Screening_Tests_and_Immunizations_for_Women.asp. Accessed August 23, 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e15" identifierName="ACIP 2018" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices"/>
                        <location value="none"/>
                        <citation
                            value="Schillie S, Vellozzi C, Reingold A, et al. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2018 Jan 12;67(No. RR-1):1–31."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e16" identifierName="VA 2017" root="LocalDocBook"/>
                        </identifiers>
                        <title value="VA PC Immunizations"/>
                        <location value="https://www.publichealth.va.gov/vaccines.asp"/>
                        <citation
                            value="U.S. Department of Veterans Affairs/Veterans Health Administrations. VA PC Immunizations. webpage. Received July 26, 2017. Accessed September 18, 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e17" identifierName="NLM 2017a" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="BEXSERO- neisseria meningitidis serogroup b nhba fusion protein antigen, neisseria meningitidis serogroup b fhbp fusion protein antigen and neisseria meningitidis serogroup b nada protein antigen injection, suspension [GlaxoSmithKline Biologicals SA"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f70cf2fc-6e6d-4a74-9f7a-db8fec072fd7"/>
                        <citation
                            value="U.S. National Library of Medicine. BEXSERO- neisseria meningitidis serogroup b nhba fusion protein antigen, neisseria meningitidis serogroup b fhbp fusion protein antigen and neisseria meningitidis serogroup b nada protein antigen injection, suspension [GlaxoSmithKline Biologicals SA]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f70cf2fc-6e6d-4a74-9f7a-db8fec072fd7. Updated September 2016."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e18" identifierName="NLM 2017b" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="BOOSTRIX- tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed suspension [GlaxoSmithKline Biologicals SA]. DailyMed website"/>
                        <location value="hhttps://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd98bff9-4602-4268-d68d-029a14a5513b"/>
                        <citation
                            value="U.S. National Library of Medicine. BOOSTRIX- tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, adsorbed suspension [GlaxoSmithKline Biologicals SA]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cd98bff9-4602-4268-d68d-029a14a5513b. Updated October 2016."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e19" identifierName="NLM 2017c" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="ENGERIX-B - hepatitis b vaccine (recombinant) injection, suspension [GlaxoSmithKline Biologicals SA]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ec65f7e-4aa2-4b41-b578-885ea59d6e9d"/>
                        <citation
                            value="U.S. National Library of Medicine. ENGERIX-B - hepatitis b vaccine (recombinant) injection, suspension [GlaxoSmithKline Biologicals SA]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=2ec65f7e-4aa2-4b41-b578-885ea59d6e9d. Updated May 2016."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e20" identifierName="NLM 2017d" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="FLUAD- influenza a virus a/california/7/2009 x-181 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/hong kong/4801/2014, nymc-x-263b (h3n2) hemagglutinin antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 - wild type hemagglutinin antigen (formaldehyde inactivated) injection, suspension [Seqirus, Inc.]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4757710-d9ac-45ea-82d0-71cb1ec32a4e"/>
                        <citation
                            value="U.S. National Library of Medicine. FLUAD- influenza a virus a/california/7/2009 x-181 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/hong kong/4801/2014, nymc-x-263b (h3n2) hemagglutinin antigen (formaldehyde inactivated) and influenza b virus b/brisbane/60/2008 - wild type hemagglutinin antigen (formaldehyde inactivated) injection, suspension [Seqirus, Inc.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d4757710-d9ac-45ea-82d0-71cb1ec32a4e. Updated July 2016."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e21" identifierName="NLM 2017e" root="LocalDocBook"/>
                        </identifiers>
                        <title value="FLUBLOK- influenza vaccine injection, solution [Protein Sciences Corporation]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf"/>
                        <citation
                            value="U.S. National Library of Medicine. FLUBLOK- influenza vaccine injection, solution [Protein Sciences Corporation]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ce88cc84-b4ed-4d59-8897-10cb53dc2edf. Updated July 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e22" identifierName="NLM 2017f" root="LocalDocBook"/>
                        </identifiers>
                        <title value="FLULAVAL QUADRIVALENT 2017/2018- influenza virus vaccine suspension [ID Biomedical Corporation of Quebec]."/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13"/>
                        <citation
                            value="U.S. National Library of Medicine. FLULAVAL QUADRIVALENT 2017/2018- influenza virus vaccine suspension [ID Biomedical Corporation of Quebec]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a9806027-8323-4abf-849f-46fb10984f13. Updated July 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e23" identifierName="NLM 2017g" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="FLUZONE HIGH-DOSE- influenza a virusa/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/hong kong/4801/2014 x-263b (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated) injection, suspension [Sanofi Pasteur Inc.]"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee"/>
                        <citation
                            value="U.S. National Library of Medicine. FLUZONE HIGH-DOSE- influenza a virusa/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/hong kong/4801/2014 x-263b (h3n2) antigen (formaldehyde inactivated), and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated) injection, suspension [Sanofi Pasteur Inc.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=81758772-80b1-4e76-8f50-e68d1fb4e9ee. Updated July 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e24" identifierName="NLM 2017h" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="FLUZONE INTRADERMAL QUADRIVALENT- influenza a virus a/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/hong kong/4801/2014 x-263b (h3n2) antigen (formaldehyde inactivated), influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated), and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated) injection, suspension [Sanofi Pasteur Inc.]"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc006704-bcdd-4416-9cbc-9cfa76145c7b"/>
                        <citation
                            value="U.S. National Library of Medicine. FLUZONE INTRADERMAL QUADRIVALENT- influenza a virus a/michigan/45/2015 x-275 (h1n1) antigen (formaldehyde inactivated), influenza a virus a/hong kong/4801/2014 x-263b (h3n2) antigen (formaldehyde inactivated), influenza b virus b/phuket/3073/2013 antigen (formaldehyde inactivated), and influenza b virus b/brisbane/60/2008 antigen (formaldehyde inactivated) injection, suspension [Sanofi Pasteur Inc.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bc006704-bcdd-4416-9cbc-9cfa76145c7b. Updated July 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e25" identifierName="NLM 2017i" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="GARDASIL 9- human papillomavirus 9-valent vaccine, recombinant injection, suspension [Merck Sharp &amp; Dohme Corp.]."/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a21f4f4b-b891-4f25-b747-cb9ec7d865d6"/>
                        <citation
                            value="U.S. National Library of Medicine. GARDASIL 9- human papillomavirus 9-valent vaccine, recombinant injection, suspension [Merck Sharp &amp; Dohme Corp.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a21f4f4b-b891-4f25-b747-cb9ec7d865d6. Updated January 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e26" identifierName="NLM 2017j" root="LocalDocBook"/>
                        </identifiers>
                        <title value="HAVRIX- hepatitis a vaccine injection, suspension [GlaxoSmithKline Biologicals SA]"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9499a4d-1288-4bd3-9d59-1d72092c38cd"/>
                        <citation
                            value="U.S. National Library of Medicine. HAVRIX- hepatitis a vaccine injection, suspension [GlaxoSmithKline Biologicals SA]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f9499a4d-1288-4bd3-9d59-1d72092c38cd. Updated May 2016."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e27" identifierName="NLM 2017k" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="MENOMUNE - A/C/Y/W-135 COMBINED- neisseria meningitidis group a capsular polysaccharide antigen, neisseria meningitidis group c capsular polysaccharide antigen, neisseria meningitidis group y capsular polysaccharide antigen and neisseria meningitidis group w-135 capsular polysaccharide antigen [Sanofi Pasteur Inc.]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4621a820-c776-4be5-abf5-018e45682770"/>
                        <citation
                            value="U.S. National Library of Medicine. MENOMUNE - A/C/Y/W-135 COMBINED- neisseria meningitidis group a capsular polysaccharide antigen, neisseria meningitidis group c capsular polysaccharide antigen, neisseria meningitidis group y capsular polysaccharide antigen and neisseria meningitidis group w-135 capsular polysaccharide antigen [Sanofi Pasteur Inc.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4621a820-c776-4be5-abf5-018e45682770. Updated February 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e28" identifierName="NLM 2017l" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="MENVEO- meningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine [Novartis Vaccines and Diagnostics s.r.l.]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dde472-1efb-4630-88bc-41cde216fb3a"/>
                        <citation
                            value="U.S. National Library of Medicine. MENVEO- meningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine [Novartis Vaccines and Diagnostics s.r.l.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=89dde472-1efb-4630-88bc-41cde216fb3a. Updated October 2016."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e29" identifierName="NLM 2017m" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="M-M-R II- measles, mumps, and rubella virus vaccine live injection, powder, lyophilized, for suspension [Merck Sharp &amp; Dohme Corp.]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9e384f-e717-436b-b9a0-15e53cef0862"/>
                        <citation
                            value="U.S. National Library of Medicine. M-M-R II- measles, mumps, and rubella virus vaccine live injection, powder, lyophilized, for suspension [Merck Sharp &amp; Dohme Corp.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a9e384f-e717-436b-b9a0-15e53cef0862. Updated May 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e30" identifierName="NLM 2017n" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="PNEUMOVAX 23- pneumococcal vaccine polyvalent injection, solution [Merck Sharp &amp; Dohme Corp.]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb362a20-6d91-4ae8-bebb-9ee8b2591814"/>
                        <citation
                            value="U.S. National Library of Medicine. PNEUMOVAX 23- pneumococcal vaccine polyvalent injection, solution [Merck Sharp &amp; Dohme Corp.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bb362a20-6d91-4ae8-bebb-9ee8b2591814. Updated July 2015."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e31" identifierName="NLM 2017o" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="PREVNAR 13- pneumococcal 13-valent conjugate vaccine injection, suspension [Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc.]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d49181b-b974-a5da-3b38-12a3a87bb96b"/>
                        <citation
                            value="U.S. National Library of Medicine. PREVNAR 13- pneumococcal 13-valent conjugate vaccine injection, suspension [Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5d49181b-b974-a5da-3b38-12a3a87bb96b. Updated April 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e32" identifierName="NLM 2017p" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="RECOMBIVAX HB- hepatitis b vaccine (recombinant) injection, suspension [Merck Sharp &amp; Dohme Corp.]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b5bd99e4-569d-48d5-ba75-16e69f8c409a"/>
                        <citation
                            value="U.S. National Library of Medicine. RECOMBIVAX HB- hepatitis b vaccine (recombinant) injection, suspension [Merck Sharp &amp; Dohme Corp.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b5bd99e4-569d-48d5-ba75-16e69f8c409a. Updated November 2014."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e33" identifierName="NLM 2017q" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="TETANUS AND DIPHTHERIA TOXOIDS ADSORBED- tetanus and diphtheria toxoids adsorbed injection [Grifols]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=664e47c7-75a8-4f7d-9384-70f36af634a2"/>
                        <citation
                            value="U.S. National Library of Medicine. TETANUS AND DIPHTHERIA TOXOIDS ADSORBED- tetanus and diphtheria toxoids adsorbed injection [Grifols]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=664e47c7-75a8-4f7d-9384-70f36af634a2. Updated March 2016."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e34" identifierName="NLM 2017r" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="TRUMENBA- meningococcal group b vaccine injection, suspension [Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc.]"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcaf5f75-caaf-41fd-875b-5800310070d1"/>
                        <citation
                            value="U.S. National Library of Medicine. TRUMENBA- meningococcal group b vaccine injection, suspension [Wyeth Pharmaceutical Division of Wyeth Holdings LLC, a subsidiary of Pfizer Inc.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=bcaf5f75-caaf-41fd-875b-5800310070d1. Updated March 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e35" identifierName="NLM 2017s" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="TWINRIX- hepatitis a and hepatitis b (recombinant) vaccine injection, suspension [GlaxoSmithKline Biologicals SA]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18e8f9fc-4d62-4d30-4ab7-bac03336171e"/>
                        <citation
                            value="U.S. National Library of Medicine. TWINRIX- hepatitis a and hepatitis b (recombinant) vaccine injection, suspension [GlaxoSmithKline Biologicals SA]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=18e8f9fc-4d62-4d30-4ab7-bac03336171e. Updated December 2016."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e36" identifierName="NLM 2017t" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="VARIVAX- varicella virus vaccine live injection, powder, lyophilized, for suspension [Merck Sharp &amp; Dohme Corp.]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=524cf052-e90e-4595-af0a-608edbe9bd31"/>
                        <citation
                            value="U.S. National Library of Medicine. VARIVAX- varicella virus vaccine live injection, powder, lyophilized, for suspension [Merck Sharp &amp; Dohme Corp.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=524cf052-e90e-4595-af0a-608edbe9bd31. Updated February 2017."
                        />
                    </resource>
                </resources>
            </evidence>
            <evidence>
                <resources>
                    <resource>
                        <identifiers>
                            <identifier extension="e37" identifierName="NLM 2017u" root="LocalDocBook"/>
                        </identifiers>
                        <title
                            value="ZOSTAVAX- zoster vaccine live injection, powder, lyophilized, for suspension; STERILE DILUENT- sterile water injection [Merck Sharp &amp; Dohme Corp.]. DailyMed website"/>
                        <location value="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30a0464e-e012-4c16-bc05-88f07e412203"/>
                        <citation
                            value="U.S. National Library of Medicine. ZOSTAVAX- zoster vaccine live injection, powder, lyophilized, for suspension; STERILE DILUENT- sterile water injection [Merck Sharp &amp; Dohme Corp.]. DailyMed website. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30a0464e-e012-4c16-bc05-88f07e412203. Updated March 2017."
                        />
                    </resource>
                </resources>
            </evidence>
        </supportingEvidence>
        <applicability>
            <coverage>
                <focus value="TargetUser"/>
                <description value="All clinical providers"/>
            </coverage>
            <coverage>
                <focus value="PatientAgeGroup"/>
                <description
                    value="Adult patients in any clinical setting (ambulatory, inpatient, etc.), including employees of the VA who are treated as patients of the VA."/>
                <value code="133936004 |Adult (person)|" codeSystem="SNOMED CT"/>
            </coverage>
            <coverage>
                <focus value="ClinicalFocus"/>
                <description value="All"/>
            </coverage>
            <coverage>
                <focus value="ClinicalVenue"/>
                <description value="Any clinical setting"/>
            </coverage>
            <coverage>
                <focus value="WorkflowTask"/>
                <description value="Routine Population-level Immunizations Recommendations"/>
            </coverage>
        </applicability>
        <status value="Active"/>
        <eventHistory>
            <artifactLifeCycleEvent>
                <eventType value="Published"/>
                <eventDateTime value="20180608"/>
            </artifactLifeCycleEvent>
            <artifactLifeCycleEvent>
                <eventType value="Reviewed"/>
                <eventDateTime value="20180608"/>
            </artifactLifeCycleEvent>
            <artifactLifeCycleEvent>
                <eventType value="Created"/>
                <eventDateTime value="20180413"/>
            </artifactLifeCycleEvent>
            <artifactLifeCycleEvent>
                <eventType value="Pre-published"/>
                <eventDateTime value="20180413"/>
            </artifactLifeCycleEvent>
        </eventHistory>
        <contributions>
            <contribution>
                <contributor xsi:type="Person">
                    <name>
                        <dt:part type="GIV" value="Denietolis"/>
                        <dt:part type="FAM" value="Angela"/>
                        <dt:part type="TITLE" value="MD"/>
                    </name>
                    <affiliation>
                        <name value="Primary Care Physician, James A. Haley Veterans Hospital, Tampa VA Medical Center (VAMC) Tampa, FL 33612"/>
                    </affiliation>
                </contributor>
                <role value="Author"/>
            </contribution>
            <contribution>
                <contributor xsi:type="Person">
                    <name>
                        <dt:part type="GIV" value="Dumas"/>
                        <dt:part type="FAM" value="Pat"/>
                        <dt:part type="TITLE" value="RN"/>
                    </name>
                    <affiliation>
                        <name value="Clinical Program Director, VA Central Office (VACO), 810 Vermont Ave NW Washington, DL 20420"/>
                    </affiliation>
                </contributor>
                <role value="Author"/>
            </contribution>
            <contribution>
                <contributor xsi:type="Person">
                    <name>
                        <dt:part type="GIV" value="Merchant"/>
                        <dt:part type="FAM" value="Manish"/>
                        <dt:part type="TITLE" value="MD"/>
                    </name>
                    <affiliation>
                        <name value="Health Informatician, Albany VAMC, 113 Holland Ave. Albany, NY 12208"/>
                    </affiliation>
                </contributor>
                <role value="Author"/>
            </contribution>
            <contribution>
                <contributor xsi:type="Person">
                    <name>
                        <dt:part type="GIV" value="Dresselhaus"/>
                        <dt:part type="FAM" value="Timothy"/>
                        <dt:part type="TITLE" value="MD"/>
                    </name>
                    <affiliation>
                        <name value="San Diego VAMC - MEDS, 3350 La Jolla Village Drive San Diego, CA 92161"/>
                    </affiliation>
                </contributor>
                <role value="Author"/>
            </contribution>
            <contribution>
                <contributor xsi:type="Person">
                    <name>
                        <dt:part type="GIV" value="Jane"/>
                        <dt:part type="FAM" value="Kim"/>
                        <dt:part type="TITLE" value="NCP"/>
                    </name>
                    <affiliation>
                        <name value="Chief Consultant for Preventive Medicine, Durham, NC"/>
                    </affiliation>
                </contributor>
                <role value="Author"/>
            </contribution>
        </contributions>
        <publishers>
            <publisher xsi:type="Organization">
                <name value="Department of Veterans Affairs"/>
            </publisher>
        </publishers>
        <usageTerms>
            <rightsDeclaration>
                <assertedRights
                    value="Copyright 2018 B3 Group, Inc.
                    NOTICE OF GOVERNMENT COPYRIGHT LICENSE AND UNLIMITED RIGHTS LICENSE
                    Licensed under the Apache License, Version 2.0 (the &quot;License&quot;); you may not use this file except in compliance with the License.
                    You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0
                    Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an &quot;AS IS&quot; BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License.
                    Portions of this content are derivative works from content produced by Cognitive Medical Systems, Inc. licensed under the Apache License, Version 2.0.
                    Additional portions of this content are derivative works from content contributed by Motive Medical Intelligence Inc., under Creative Commons Attribution-ShareAlike 4.0.
                    Contributions from 2013-2018 were performed either by US Government employees, or under US Veterans Health Administration contracts.
                    US Veterans Health Administration contributions by government employees are work of the U.S. Government and are not subject to copyright protection in the United States. Portions contributed by government employees are USGovWork (17USC §105). Not subject to copyright.
                    See: https://www.usa.gov/government-works
                    Contribution by contractors to the US Veterans Health Administration during this period are contractually contributed under the Apache License, Version 2.0 and US Government sponsorship is acknowledged under Contract VA118-16-D-1008, Task Order VA11817F10080007."/>
                <rightsHolder xsi:type="Organization">
                    <name value="B3 Group, Inc."/>
                </rightsHolder>
            </rightsDeclaration>
            <rightsDeclaration>
                <assertedRights
                    value="Copyright 2018 Cognitive Medical Systems, Inc.
                    Licensed under the Apache License, Version 2.0 (the &quot;License&quot;); you may not use this file except in compliance with the License.
                    You may obtain a copy of the License at http://www.apache.org/licenses/LICENSE-2.0
                    Unless required by applicable law or agreed to in writing, software distributed under the License is distributed on an &quot;AS IS&quot; BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied. See the License for the specific language governing permissions and limitations under the License.
                    This and related content produced by Cognitive Medical Systems, Inc. licensed under the Apache License, Version 2.0 is available at: https://bitbucket.org/cogmedsys/hl7-kas-examples
                    Additional portions of this content are derivative works from content contributed by Motive Medical Intelligence Inc., under Creative Commons Attribution-ShareAlike 4.0. https://bitbucket.org/cogmedsys/kas-source-material
                    Contributions from 2013-2018 were performed either by US Government employees, or under US Veterans Health Administration contracts.
                    US Veterans Health Administration contributions by government employees are work of the U.S. Government and are not subject to copyright protection in the United States. Portions contributed by government employees are USGovWork (17USC §105). Not subject to copyright. See: https://www.usa.gov/government-works
                    Contribution by contractors to the US Veterans Health Administration during this period are contractually contributed under the Apache License, Version 2.0 and US Government sponsorship is acknowledged under Contract VA118-16-D-1008-0007."/>
                <rightsHolder xsi:type="Organization">
                    <addresses>
                        <address>
                            <dt:part type="AL" value="10156 Tapestry Ct"/>
                            <dt:part type="ADL" value=""/>
                            <dt:part type="CTY" value="Fairfax"/>
                            <dt:part type="STA" value="VA"/>
                            <dt:part type="ZIP" value="22032"/>
                        </address>
                    </addresses>
                    <name value="B3 Group, Inc."/>
                </rightsHolder>
            </rightsDeclaration>
        </usageTerms>
    </metadata>
    <externalData>
        <codesystem name="SNOMED CT" id="2.16.840.1.113883.6.96" version="United States Edition 20180301"/>
    </externalData>
    <actionGroup>
        <title value="Recommended Immunizations: Order Set"/>
        <subElements>
            <actionGroup>
                <title value="Hepatitis Immunizations"/>
                <subElements>
                    <!--Condition: This subsection should be made available for patients for whom the Hepatitis A Immunization branch of the Immunizations General ECA rule KNART is true.-->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Hepatitis A Vaccine (0 and 6 to 18 Months)"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Hepatitis A vaccine 1 mL solution intramuscular 1 time give injection in the deltoid region now"/>
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- This subsection should be made available for patients for whom the Hepatitis A Immunization branch of the Immunizations General ECA rule KNART is true -->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Combined Hepatitis A and B Vaccine Series (0, 1, and 6 Months)"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Hepatitis A and hepatitis B (recombinant) vaccine 1 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- Condition: This subsection should be made available for patients < 20 years for whom the Hepatitis B Immunization branch of the Immunizations General ECA rule KNART is true.-->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Hepatitis B Vaccine (0, 1, and 6 Months) for Age &lt; 20 Years"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Hepatitis B vaccine (recombinant) 10 micrograms/mL formulation 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Hepatitis B vaccine (recombinant) 20 micrograms/mL formulation 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- Condition: This subsection should be made available for patients >= 20 years for whom the Hepatitis B Immunization branch of the Immunizations General ECA rule KNART is true.-->

                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Hepatitis B Vaccine Series (0, 1, and 6 Months) for Age >= 20 Years"/>
                        <description
                            value="Adults in the following settings are assumed to be at risk for hepatitis B virus infection and should receive a HepB series: sexually transmitted disease treatment facilities, HIV testing and treatment facilities, facilities providing drug-abuse treatment and prevention services, healthcare settings targeting services to persons who inject drugs, correctional facilities, healthcare settings targeting services to men who have sex with men, hemodialysis facilities and end-stage renal disease programs, and institutions and nonresidential day care facilities for developmentally disabled persons"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Hepatitis B vaccine (recombinant) 10 micrograms/mL formulation 1 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Hepatitis B vaccine (recombinant) 20 micrograms/mL formulation 1 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- Condition: This subsection should be made available for patients on dialysis for whom the Hepatitis B Immunization branch of the Immunizations General ECA rule KNART is true. -->
                    <!-- Condition: The order for the hepatitis B vaccine (recombinant) 40 micrograms/mL formulation should not be displayed for patients who have already received at least one dose of the hepatitis B vaccine (recombinant) 20 micrograms/mL formulation. -->
                    <!-- Condition: The order for the hepatitis B vaccine (recombinant) 20 micrograms/mL formulation should not be displayed for patients who have already received at least one dose of the hepatitis B vaccine (recombinant), 40 micrograms/mL formulation -->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Hepatitis B Vaccine Series (0, 1, and 6 Months or 0, 1, 2, and 6 Months) for Dialysis Patients"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Hepatitis B vaccine (recombinant) 40 micrograms/mL formulation 1 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Hepatitis B vaccine (recombinant) 20 micrograms/mL formulation 2 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                </subElements>
            </actionGroup>
            <!--Herpes Zoster (Shingles) Immunization  -->
            <!-- Condition: This subsection should be made available for patients for whom the Herpes Zoster (Shingles) Immunization branch of the Immunizations General ECA rule KNART is true.-->
            <actionGroup>
                <behaviors>
                    <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                </behaviors>
                <title value="Herpes Zoster (Shingles) Immunization"/>
                <description value="The new version released January 2018 by the CDC https://www.cdc.gov/mmwr/volumes/67/wr/mm6703a5.htm"/>
                <subElements>
                    <simpleAction xsi:type="CreateAction">
                        <textEquivalent
                            value="Zoster vaccine live injection, powder, lyophilized 0.65 mL solution subcutaneous 1 time give injection in deltoid region now"
                        />
                    </simpleAction>
                </subElements>
            </actionGroup>
            <!-- Human Papillomavirus (HPV) Vaccine Series (0, 2, and 6 Months) -->
            <!-- Condition: This subsection should be made available for patients for whom the HPV Immunization branch of the Immunizations ECA rule KNART is true.-->
            <actionGroup>
                <behaviors>
                    <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                </behaviors>
                <title value="Human Papillomavirus (HPV) Vaccine Series (0, 2, and 6 Months)"/>
                <description value="Human Papillomavirus (HPV) Vaccine CDC guidelines https://www.cdc.gov/hpv/index.html"/>
                <subElements>
                    <simpleAction xsi:type="CreateAction">
                        <textEquivalent
                            value="HPV 9-valent vaccine, recombinant injection 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"
                        />
                    </simpleAction>
                </subElements>
            </actionGroup>
            <!-- Influenza Immunization -->
            <!-- This subsection should be made available for patients for whom the Influenza Immunizations: Standard-Dose Inactivated Influenza Vaccine (IIV) sub-branch of the Influenza Immunization General ECA rule KNART is true. -->
            <actionGroup>
                <title value="Influenza Immunization"/>
                <description
                    value="Please see ACIP’s Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States, 2017 (https://www.cdc.gov/vaccines/schedules/downloads/adult/adult-combined-schedule.pdf)."/>
                <subElements>
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Standard-Dose Inactivated Influenza Vaccine (IIV)"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Influenza inactivated virus vaccine 0.5 mL solution intramuscular 1 time give injection in the deltoid region now."/>
                                <actionSentence xsi:type="elm:Instance" classType="anf:ClinicalStatement">
                                    <elm:element name="statementType">
                                        <elm:value xsi:type="elm:Code" code="385644000 |Requested (qualifier value)|"
                                            display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="topic">
                                        <elm:value xsi:type="elm:Code"
                                            code="[416118004 |Administration (procedure)]
                                            ->(260686004 |Method (attribute))->[129326001 |Injection - action (qualifier value)]-
                                            ->(363701004 |Direct substance (attribute))->[408752008 |Inactivated influenza split virion vaccine (product)]-
                                            ->(410675002 |Route of administration (attribute))->[78421000 |Intramuscular route (qualifier value)]-
                                            ->(405813007 |Procedure site - Direct (attribute))->[37622008 |Deltoid region structure (body structure)];"
                                            display="Postcoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="requestedResult.lowerBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Decimal" value="0.5"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.upperBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Decimal" value="0.5"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.includeLowerBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Boolean" value="true"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.includeUpperBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Boolean" value="true"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.measureSemantic">
                                        <elm:value xsi:type="elm:Code" code="258773002 |Milliliter (qualifier value)|"
                                            display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="priority">
                                        <elm:value xsi:type="elm:Code" code="50811001 |Routine (qualifier value)|" display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                </actionSentence>
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- This subsection should be made available for patients for whom the Influenza Immunizations: Recombinant Influenza Vaccine (RIV) sub-branch of the Influenza Immunization General ECA rule KNART is true. -->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Recombinant Influenza Vaccine (RIV)"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Influenza virus vaccine (recombinant) 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"/>
                                <actionSentence xsi:type="elm:Instance" classType="anf:ClinicalStatement">
                                    <elm:element name="statementType">
                                        <elm:value xsi:type="elm:Code" code="385644000 |Requested (qualifier value)|"
                                            display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="topic">
                                        <elm:value xsi:type="elm:Code"
                                            code="[416118004 |Administration (procedure)]
                                            ->(260686004 |Method (attribute))->[129326001 |Injection - action (qualifier value)]-
                                            ->(363701004 |Direct substance (attribute))->[46233009 |Influenza virus vaccine (product)]-
                                            ->(410675002 |Route of administration (attribute))->[78421000 |Intramuscular route (qualifier value)]-
                                            ->(405813007 |Procedure site - Direct (attribute))->[37622008 |Deltoid region structure (body structure)];"
                                            display="Postcoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="unstructured[0]">
                                        <elm:value xsi:type="elm:Literal" valueType="String" value="recombinant"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.lowerBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Decimal" value="0.5"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.upperBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Decimal" value="0.5"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.includeLowerBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Boolean" value="true"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.includeUpperBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Boolean" value="true"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.measureSemantic">
                                        <elm:value xsi:type="elm:Code" code="258773002 |Milliliter (qualifier value)|"
                                            display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="priority">
                                        <elm:value xsi:type="elm:Code" code="50811001 |Routine (qualifier value)|" display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                </actionSentence>
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- This subsection should be made available for patients for whom the Influenza Immunizations: Intradermal IIV sub-branch of the Influenza Immunization General ECA rule KNART is true. -->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Intradermal IIV"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Intradermal influenza inactivated virus vaccine 0.1 mL solution intradermal 1 time give injection in the deltoid region now"/>
                                <actionSentence xsi:type="elm:Instance" classType="anf:ClinicalStatement">
                                    <elm:element name="statementType">
                                        <elm:value xsi:type="elm:Code" code="385644000 |Requested (qualifier value)|"
                                            display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="topic">
                                        <elm:value xsi:type="elm:Code"
                                            code="[416118004 |Administration (procedure)]
                                            ->(260686004 |Method (attribute))->[129326001 |Injection - action (qualifier value)]-
                                            ->(363701004 |Direct substance (attribute))->[46233009 |Influenza virus vaccine (product)]-
                                            ->(410675002 |Route of administration (attribute))->[372464004 |Intradermal route (qualifier value)]-
                                            ->(405813007 |Procedure site - Direct (attribute))->[37622008 |Deltoid region structure (body structure)];"
                                            display="Postcoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="unstructured[0]">
                                        <elm:value xsi:type="elm:Literal" valueType="String" value="inactivated"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.lowerBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Decimal" value="0.1"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.upperBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Decimal" value="0.1"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.includeLowerBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Boolean" value="true"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.includeUpperBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Boolean" value="true"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.measureSemantic">
                                        <elm:value xsi:type="elm:Code" code="258773002 |Milliliter (qualifier value)|"
                                            display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="priority">
                                        <elm:value xsi:type="elm:Code" code="50811001 |Routine (qualifier value)|" display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                </actionSentence>
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- This subsection should be made available for patients for whom the Influenza Immunizations: High-Dose or Adjuvanted IIV sub-branch of the Influenza Immunization General ECA rule KNART is true. -->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="High-Dose or Adjuvanted IIV"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Influenza high-dose inactivated virus vaccine 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"/>
                                <actionSentence xsi:type="elm:Instance" classType="anf:ClinicalStatement">
                                    <elm:element name="statementType">
                                        <elm:value xsi:type="elm:Code" code="385644000 |Requested (qualifier value)|"
                                            display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="topic">
                                        <elm:value xsi:type="elm:Code"
                                            code="[416118004 |Administration (procedure)]
                                            ->(260686004 |Method (attribute))->[129326001 |Injection - action (qualifier value)]-
                                            ->(363701004 |Direct substance (attribute))->[408752008 |Inactivated influenza split virion vaccine (product)]-
                                            ->(410675002 |Route of administration (attribute))->[78421000 |Intramuscular route (qualifier value)]-
                                            ->(405813007 |Procedure site - Direct (attribute))->[37622008 |Deltoid region structure (body structure)];"
                                            display="Postcoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="unstructured[0]">
                                        <elm:value xsi:type="elm:Literal" valueType="String" value="high-dose"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.lowerBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Decimal" value="0.5"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.upperBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Decimal" value="0.5"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.includeLowerBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Boolean" value="true"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.includeUpperBound">
                                        <elm:value xsi:type="elm:Literal" valueType="Boolean" value="true"/>
                                    </elm:element>
                                    <elm:element name="requestedResult.measureSemantic">
                                        <elm:value xsi:type="elm:Code" code="258773002 |Milliliter (qualifier value)|"
                                            display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                    <elm:element name="priority">
                                        <elm:value xsi:type="elm:Code" code="50811001 |Routine (qualifier value)|" display="Precoordinated Expression">
                                            <elm:system name="SNOMED CT"/>
                                        </elm:value>
                                    </elm:element>
                                </actionSentence>
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                </subElements>
            </actionGroup>
            <!-- Meningococcal Immunizations -->
            <!-- Condition:This subsection should be made available for patients for whom the Meningococcal Immunizations: Serogroups A, C, W, and Y Conjugate Vaccine (MenACWY) Series and Boosters sub-branches of the Meningococcal Immunizations General ECA rule KNART is true. -->
            <actionGroup>
                <title value="Meningococcal Immunizations"/>
                <description
                    value="Meningococcal vaccines should be used during pregnancy only if clearly needed. Health care providers are encouraged to register women who receive a meningococcal vaccine during pregnancy. See package inserts at: https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/default.htm."/>
                <subElements>
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Serogroups A, C, W, and Y Conjugate Vaccine (MenACWY) Series and Boosters"/>
                        <description
                            value="CDC newly published this recommendation regarding eculizumab and meningococcal vaccination in the July 7, 2017 https://www.cdc.gov/meningococcal/clinical/eculizumab.html."/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Meningococcal (groups a, c, y, and w-135) oligosaccharide diphtheria crm197 conjugate vaccine 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- Condition: This subsection should be made available for patients for whom any of the Meningococcal Immunizations: Serogroup B Meningococcal Vaccine (MenB) Series sub-branches of the Meningococcal Immunizations General ECA rule KNART is, providing the patient has not had a prior MenB-FHbp immunization. -->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Serogroup B Meningococcal Vaccine: MenB-4C Series (0 and 1 Month)"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Neisseria meningitidis serogroup b-4c protein antigen vaccine 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- Condition: This subsection should be made available for patients for whom any of the Meningococcal Immunizations: Serogroup B Meningococcal Vaccine (MenB) Series sub-branches of the Immunizations ECA rule KNART is true, providing the patient has not had a prior MenB-4C immunization. -->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title
                            value="Serogroup B Meningococcal Vaccine: MenB-Fhbp Series (0, 1 to 2, and 6 Months or 0 and 6 Months, Based on Indications)"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Neisseria meningitidis serogroup b-FHbp protein antigen vaccine 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                </subElements>
            </actionGroup>
            <!-- Measles, Mumps, and Rubella (MMR) Immunizations -->
            <!-- Condition: This subsection should be made available for patients for whom the Measles, Mumps, and Rubella Immunizations: Adults Requiring Two Doses of MMR sub-branch of the Measles, Mumps and Rubella Immunizations General ECA rule KNART is true. -->
            <actionGroup>
                <title value="Measles, Mumps, and Rubella (MMR) Immunizations"/>
                <description
                    value="Please note that ACIP published updated guidance on MMR immunizations https://www.cdc.gov/mmwr/volumes/67/wr/mm6701a7.htm"/>
                <subElements>
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Measles, Mumps, and Rubella Vaccine Series (0 and 28 Days)"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Measles, mumps, and rubella virus vaccine live injection, powder, lyophilized 0.5 mL solution subcutaneous 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!--Condition: This subsection should be made available for patients for whom either the Measles, Mumps, and Rubella Immunizations: Adults Requiring One Dose of MMR or the Measles, Mumps, and Rubella Immunizations: Women Who Are Postpartum or Post-termination sub-branch of the Measles, Mumps and Rubella Immunizations General ECA rule KNART is true.  -->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Measles, Mumps, and Rubella Vaccine"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Measles, mumps, and rubella virus vaccine live injection, powder, lyophilized 0.5 mL solution subcutaneous 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                </subElements>
            </actionGroup>
            <!-- Pneumococcal Immunization -->
            <!-- Condition: This subsection should be made available for patients for whom the Pneumococcal Immunizations General ECA rule is true for any of the following: 1) the "Pneumococcal Immunizations: 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Younger Adults with Asplenia or Immunocompromise" sub-branch; or 2) the "Pneumococcal Immunizations: 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Younger Adults with a Cerebrospinal Fluid Leak or a Cochlear Implant" sub-branch; or 3) the "Pneumococcal Immunizations: 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Older Adults with Asplenia, Immunocompromise, Cerebrospinal Fluid Leak, or Cochlear Implant" sub-branch; or 4) the "Pneumococcal Immunizations: 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Immunocompetent Older Adults" sub-branch.-->
            <actionGroup>
                <title value="Pneumococcal Immunization"/>
                <description
                    value="Pneumococcal Immunization CDC guidelines https://www.cdc.gov/vaccines/vpd/pneumo/hcp/recommendations.html. Both Pneumococcal Polysaccharide Vaccine (PPSV23) and Pneumococcal Conjugate Vaccine (PCV13) should be given to a pregnant woman only if clearly needed. Pregnancy is not an absolute contraindication."/>
                <subElements>
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="13-Valent Pneumococcal Conjugate Vaccine"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Pneumococcal 13-valent conjugate vaccine 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- Condition: [Technical Note: This subsection should be made available for patients for whom the Pneumococcal Immunizations General ECA rule is true for any of the following: 
1.	The "Pneumococcal Immunizations: Initial 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) for Younger Adults with Asplenia or Immunocompromise " sub-branch 
2.	The "Pneumococcal Immunizations: Second 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) for Younger Adults with Asplenia or Immunocompromise" sub-branch 
3.	The "Pneumococcal Immunizations: 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) for Younger Adults with a Cerebrospinal Fluid Leak or a Cochlear Implant" sub-branch
4.	The "Pneumococcal Immunizations: 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) for Younger Adults with Certain Medical Conditions" sub-branch
5.	The "Pneumococcal Immunizations: 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) for Older Adults with Asplenia, Immunocompromise, Cerebrospinal Fluid Leak, or Cochlear Implant" sub-branch
6.	The "Pneumococcal Immunizations: 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) for Immunocompetent Older Adults" sub-branch. -->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="23-Valent Pneumococcal Polysaccharide Vaccine"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Pneumococcal polyvalent-23 vaccine 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                </subElements>
            </actionGroup>
            <!-- Tetanus, Diphtheria, and Pertussis Immunization -->
            <!-- Condition: This subsection should be made available for patients for whom the Tetanus, Diphtheria, Pertussis Immunizations: Tdap sub-branch of the Tetanus, Diphtheria, Pertussis Immunizations General ECA rule KNART is true.-->
            <actionGroup>
                <title value="Tetanus, Diphtheria, and Pertussis Immunization"/>
                <description
                    value="Tetanus, Diphtheria, and Pertussis Immunization CDC Guidelines https://www.cdc.gov/vaccines/vpd/dtap-tdap-td/hcp/recommendations.html"/>
                <subElements>
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Tetanus, Diphtheria, and Pertussis Vaccine"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                    <!-- Condition: This subsection should be made available for patients for whom either the Tetanus, Diphtheria, Pertussis Immunizations: Td or Tetanus, Diphtheria, Pertussis Immunizations: Td Vaccine Booster sub-branch of the Tetanus, Diphtheria, Pertussis Immunizations General ECA rule KNART is true.-->
                    <actionGroup>
                        <behaviors>
                            <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                        </behaviors>
                        <title value="Tetanus and Diphtheria Vaccine"/>
                        <subElements>
                            <simpleAction xsi:type="CreateAction">
                                <textEquivalent
                                    value="Tetanus and diphtheria toxoids vaccine 0.5 mL solution intramuscular 1 time give injection in the deltoid region now"
                                />
                            </simpleAction>
                        </subElements>
                    </actionGroup>
                </subElements>
            </actionGroup>
            <!-- Varicella Immunization -->
            <!-- Condition: This section should be made available for patients for whom any branch or sub-branch of the Immunizations General ECA rule KNART is true.-->
            <actionGroup>
                <behaviors>
                    <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                </behaviors>
                <title value="Varicella Immunization"/>
                <description value="Varicella Immunization CDC Guidelines https://www.cdc.gov/vaccines/vpd/varicella/hcp/index.html"/>
                <subElements>
                    <simpleAction xsi:type="CreateAction">
                        <textEquivalent
                            value="Varicella live virus vaccine 0.5 mL solution subcutaneous 1 time give injection in the deltoid region now"/>
                    </simpleAction>
                </subElements>
            </actionGroup>
            <!-- Patient and Caregiver Education -->
            <!-- Condition: This section should be made available for patients for whom any branch or sub-branch of the Immunizations General ECA rule KNART is true.-->
            <actionGroup>
                <behaviors>
                    <behavior xsi:type="GroupSelectionBehavior" value="Any"/>
                </behaviors>
                <title value="Patient and Caregiver Education"/>
                <subElements>
                    <simpleAction xsi:type="CreateAction">
                        <textEquivalent value="Vaccine education (patient-appropriate material regarding ordered vaccines) now"/>
                    </simpleAction>
                </subElements>
            </actionGroup>
        </subElements>
    </actionGroup>
</knowledgeDocument>
